TREATMENT OUTCOMES AND CLINICAL RELEVANCE IN PATIENTS WITH DOUBLE EXPRESSOR DLBCL
Background: Double-expressor lymphoma (DEL) was found accounting for 20- 30% of DLBCL. We conducted this study to analyze the survival, the clinical presentation and the factors associated with treatment outcomes in DEL-DLBCL. Methods: A retrospective study of 291 patients diagnosed with DLBCL d...
Main Author: | PIMJAI NIPARUCK |
---|---|
Format: | Article |
Language: | English |
Published: |
PAGEPress Publications
2021-10-01
|
Series: | Mediterranean Journal of Hematology and Infectious Diseases |
Subjects: | |
Online Access: | http://mjhid.org/index.php/mjhid/article/view/4709 |
Similar Items
-
Treatment outcome and prognostic factors in PCNSL
by: Pimjai Niparuck, et al.
Published: (2019-06-01) -
PROGNOSTIC VALUE OF pSTAT3 EXPRESSION IN DIFFUSIVE B-LARGE CELL LYMPHOMA IN THE RUSSIAN PATIENT SAMPLE
by: E. V. Vaneeva, et al.
Published: (2019-11-01) -
Prognostic value of interim PET/CT in GCB and non-GCB DLBCL: comparison of the Deauville five-point scale and the ΔSUVmax method
by: Na Sun, et al.
Published: (2024-12-01) -
Analysis of Diffuse Large B Cell Lymphoma using Immunohistochemistry to Identify Double Expressor Diffuse Large B Cell Lymphoma among Germinal Centre and Non Germinal Centre B Cell Subtypes
by: E R Jyothi Rani, et al.
Published: (2024-08-01) -
Primary, non-germinal center, double-expressor diffuse large B cell lymphoma confined to a uterine leiomyoma: A case report
by: Alexandra Martin, et al.
Published: (2017-11-01)